Targeting the Hippo Transducer TAZ in Breast Cancer With Statins
Status:
Unknown status
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This pre-surgical, window-of-opportunity study is designed to investigate whether
atorvastatin reduces the proliferation marker Ki-67 via modulation of the Hippo transducer
TAZ.